Showing results (121-130 of 279) with videos related to

Sort By:
Pageof 28
American Journal of Hypertension|July 2, 2016
Comparison of Blood Pressure Control Rates Among Recommended Drug Selection Strategies for Initial Therapy of HypertensionKamel A Gharaibeh, Stephen T Turner, Abdurrahman M Hamadah, et al.
Kidney International Reports|November 17, 2017
A Drug Development Tool for Trial Enrichment in Patients With Autosomal Dominant Polycystic Kidney DiseaseRonald D Perrone, Mohamad-Samer Mouksassi, Klaus Romero, et al.
Scientific Reports|February 22, 2023
Atypical Polycystic Kidney Disease as defined by ImagingIoan-Andrei Iliuta, Aung Zaw Win, Matthew B Lanktree, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|October 14, 2022
Clonal Hematopoiesis of Indeterminate Potential and Kidney Function Decline in the General PopulationBryan Kestenbaum, Alexander G Bick, Caitlyn Vlasschaert, et al.
Frontiers in Genetics|December 6, 2019
Genome-Wide Study Updates in the International Genetics and Translational Research in Transplantation Network (iGeneTRAiN)Claire E Fishman, Maede Mohebnasab, Jessica van Setten, et al.
The New England Journal of Medicine|November 7, 2017
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney DiseaseVicente E Torres, Arlene B Chapman, Olivier Devuyst, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 3, 2009
MRI-based kidney volume measurements in ADPKD: reliability and effect of gadolinium enhancementKyongtae T Bae, Cheng Tao, Fang Zhu, et al.
Biorxiv : the Preprint Server for Biology|January 23, 2024
Cardiac Localized Polycystin-2 plays a Functional Role in Natriuretic Peptide Production and its Absence Contributes to HypertensionBrandon Elliott, Karla M Márquez-Nogueras, Paula Thuo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 19, 2015
Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 TrialRon T Gansevoort, Esther Meijer, Arlene B Chapman, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 24, 2017
Blood pressure response to metoprolol and chlorthalidone in European and African Americans with hypertensionMai Mehanna, Yan Gong, Caitrin W McDonough, et al.
Pageof 28